OBJECTIVE: To assess whether the extent of abdominal fat distribution, as measured by the waist to hip ratio (WHR), might account for the sex differences in the levels of cardiovascular risk factors. DESIGN: Cross-sectional age-matched study. SUBJECTS: 1264 men and 1264 premenopausal women, aged 30 ± 49 y, free from known cardiovascular diseases and diabetes, included in the prospective study, D.E.S.I.R. MEASUREMENTS: (1) body mass index (BMI), WHR and blood pressures; (2) fasting concentrations of blood glucose, insulin, lipids and lipoprotein subfractions, and apolipoproteins; and (3) smoking status, physical activity, and alcohol consumption. RESULTS: After taking into account age and BMI, there were gradual relationships, within and across sexes, between WHR and the levels of most lipids and lipoproteins, of fasting glucose and insulin, and, to a lesser extent, of blood pressures. In particular, men and women with similar BMI and WHR had similar levels of triglycerides. Multivariate regression analysis showed that the variance of cardiovascular risk factors explained by the model was increased when sex was included, after controlling for age, BMI and lifestyle habits (all P`0.01). If WHR was included in the model, sex had no additional effect on total cholesterol (P b 0.09 for change in total r 2 ) or triglycerides (P b 0.40 for change in total r 2 ). In contrast, for other cardiovascular risk factors, adjustment for covariates and WHR did not fully eliminate the sex differences, although WHR increased the variance explained with or without additional control for sex (all P`0.01). CONCLUSION: The continuous increase of cardiovascular risk factors with WHR, especially for lipids and lipoproteins, suggests that the abdominal body fat distribution may partially explain the relative unhealthier cardiovascular risk pro®le of men.
Introduction
Despite the differences in cardiovascular disease (CVD) morbidity and mortality between and within countries, 1 the excess risk in middle-aged men in industrialized countries as compared to women of the same age is consistent. 1, 2 It has been suggested that the relative disadvantage of men for these diseases is mediated through more frequent unhealthy behaviour, such as cigarette smoking, and differences in atherogenic factors, including total cholesterol and blood pressure. 3, 4 However, as reviewed recently from prospective studies, controlling for these various factors does not fully eliminate the gender gap in coronary artery disease risk. 5 Additional adjustment for obesity status or relative weight, as assessed by body mass index (BMI) has little effect on the sex differential in the incidence of coronary artery disease. 5 However, the association between overweight and heart disease is greatly in¯uenced by the extent of abdominal body fat. 6 ± 8 Abdominal adiposity has been shown to be a strong predictor of cardiovascular events, independently of other cardiovascular risk factors, 6 ± 9 whereas the degree of overall obesity has not always been found to be an independent determinant. 7, 8, 10 On the other hand, abdominal fat distribution is predominantly a male fat pattern. Indeed, Vague 11 noted four decades ago, that while men tend to store fat in the trunk, especially in the visceral area, premenopausal healthy women accumulate fat preferentially in the hips and thighs. Consequently, it has been proposed that the differences in the regional fat distribution may account for the differential in CVD rates between men and women, as reported among middle-aged Swedish men and women. 12 The fact that when women become diabetic, they lose their cardiovascular protection 13 supports this hypothesis, since diabetic women often have a more pronounced android fat pattern than non diabetic women. Similarly, the redistribution of fat toward a more abdominal localization, which occurs after menopause, 14, 15 could explain the increased and accelerated incidence of CVD in postmenopausal women who do not receive hormone replacement therapy. 16, 17 In both sexes, abdominal adipose tissue, either overall or visceral, is positively related to metabolic disturbances, including dyslipidaemia, glucose intolerance, hyperinsulinaemia and insulin resistance, as well as hypertension. 18 ± 21 Moreover, these abnormalities are known to cluster and to increase the risk of developing CVD. 22 Accordingly, some studies suggested that stratifying or adjusting for the level of abdominal adiposity, 23, 24 especially visceral fat accumulation, 25 reduces the gender differences in other cardiovascular risk factors. However, it remains unclear whether an abdominal fat distribution per se accounts for the sex differences in cardiovascular risk factor levels, or whether the associations are confounded by different lifestyle habits, which may in¯uence both adiposity and metabolic parameters. 26 ± 29 In addition, the sexual dimorphism of body fat distribution has led abdominal fat to be considered as a sex-speci®c characteristic, rather than as a continuous factor that could progressively in¯uence the cardiovascular risk pro®le, independently of sex.
The aim of this study was to investigate the relationships between the degree of abdominal fat, as measured by the waist to hip ratio (WHR), and the levels of other cardiovascular risk factors in a large sample of healthy middle-aged French men and premenopausal women, of similar ages. We also assessed to what extent an android fat distribution explained the sex variations in cardiovascular risk factors, after adjustment for confounding variables, such as age, relative weight and lifestyle habits.
Materials and methods

Study population
This cross-sectional analysis used the baseline data of subjects included in the 9-y follow-up D.E.S.I.R. Study (Data from Epidemiologic Study on the Insulin Resistance syndrome). 30 Between September 1994 and February 1996, 5214 men and non-pregnant women from the Center-West of France, aged from 30 to 65 y, signed a statement of informed consent to be enrolled. All subjects were insured by the French Social Security System and they were invited to participate in the study when they volunteered for a free periodic check-up in one of the ten health centers. The protocol was approved by the CCPPRB (Comite Â Consultatif de la Protection des Personnes pour la Recherche Biome Âdicale) of Bice Ãtre, by the CNIL (Commission Nationale de l'Informatique et des Liberte Âs), and INSERM (Institut National de la Sante Â et de la Recherche Me Âdicale) was the promoter.
Data collection
Each participant underwent a standard examination. Blood was drawn after 12 h of fasting. Serum insulin was centrally measured at the IRSA (Regional Institute of Health, in Tours) laboratory by a microenzyme immunoassay (IMx-Abbott, Rungis, France) which does not cross-react with proinsulin, 31 whereas the conventional radioimmunoassay is unable to segregate insulin from proinsulin and its by-products. All other biochemical measurements were from one of the three health center laboratories (IRSA, Blois or Orleans), which maintained an inter-laboratory quality control during the period of the study. A DAX 24 (Bayer, Puteaux, France) or a KONE (Evry, France) were used to assay total cholesterol, triglycerides and, after phosphotungstic acid ± Mg precipitation, highdensity lipoprotein (HDL)-cholesterol. Apolipoprotein A-I, apolipoprotein-B, lipoprotein(a) were quanti®ed by immunonephelemetry using the BNA system (Behring, Rueil-Malmaison, France). Low-densitylipoprotein (LDL)-cholesterol concentration was computed with the Dahlen formula, 32 only for subjects who had a triglyceride value 4 mmolal (350 mgadl). To assay glucose, the glucose ± oxidase method was applied to¯uoro-oxalated plasma using a Technicon RA 1000 (Bayer, Puteaux, France). The inter-laboratory variability was assessed monthly on normal and pathological values for each biologic variable, the coef®cients of variation for laboratories were lower than 6% over the period of inclusion.
A medical interview provided information about menopausal status, use of medication, personal and familial history of chronic diseases such as diabetes, hypertension, CVD. Subjects were classi®ed as diabetic if they reported to be diabetic and were treated by hypoglycaemic drugs or on a diet, or if they had a fasting glucose level 7.8 mmolal (140 mgadl. WHO 1980 criteria 33 ). Anthropometric measures were taken by trained medical persons. Methods were standardized in the ten health centers. Weight (kg) and height (m) were measured with subjects wearing only underwear and without shoes, and the BMI ( weightaheight 2 ) computed as a relative weight index. Waist and hip circumferences were taken A study-speci®c self-administered questionnaire was used to collect lifestyle data. Smoking status was categorized as current, former or never. Physical activity was assessed on the usual activity at work andaor at home (low, moderate, important, intensive) and regularity of playing sport (never, less than once per week, one or two times per week, more than twice per week). A subject was considered as sedentary when he did not play sport at least once per week and when his physical activity was low or moderate. Alcohol intake was estimated in grams of alcohol per day, from a validated semi-quantitative questionnaire 34 about the current daily alcohol intake of wine, beer or cider, and the weekly consumption of spirits.
Statistical analysis
To examine the gender differences between abdominal body-fat distribution and cardiovascular risk factors levels, the cohort was restricted to subjects with measures of WHR, free from cardiovascular events and without diabetes. Postmenopausal women were not included because of their possible altered cardiovascular risk pro®le, as compared to premenopausal women. Since most of the women aged 50 y and older had undergone menopause, the age was limited to 30 ± 49 y in both sexes. Furthermore, we excluded the more obese subjects who had a BMI value over the 95th percentile of the sex and 5-y age speci®c distribution to eliminate possible inaccurate measures of WHR. Finally, an age-matched sample of 1264 men and 1264 premenopausal women was analysed.
All analyses were performed with the Statistical Analysis System. 35 Characteristics are expressed in terms of means, standard deviations and P-values of the two-tailed Student's t test. Because of the skewed distributions of fasting insulin and triglycerides, these variables were logarithmically transformed and geometric means, as well as 95% con®dence intervals (CI), are presented. The WHR values were divided into nine intervals each covering a range of 0.05: 0.65; (0.65 ± 0.69); up to (0.95 ± 0.99); and 1.00. The age and BMI-adjusted means within each sex and WHR class were calculated by analysis of covariance, grouping men and women in the same model. For biological parameters (except for insulin), the difference between the three laboratories was additionally controlled for, using two binary variables. Adjusted means were also calculated by sex and WHR class in each tertile of BMI (lowest: BMI 22.0 kgam 2 ; middle: 22.0`BMI 24.6 kgam 2 ; highest: BMI b 24.6 kgam 2 ). Differences in lifestyle factors were tested by the w 2 test. For each cardiovascular risk factor, we compared by Fisher's test for nested multiple linear regression models, the total percentage of the variance explained by the model (r 2 ) after controlling for: (1) covariates (age, BMI, smoking status, overall physical activity and alcohol consumption per day; (2) covariates and sex; (3) covariates and WHR; and (4) covariates, sex and WHR.
Results
Cross-sectional comparisons indicated that men and women, matched for age, had signi®cantly different mean values for the main biological and clinical variables related to cardiovascular risk (Table 1) . Men had higher mean levels of total and LDL-cholesterol, triglycerides, apolipoprotein-B, fasting glucose and insulin, systolic and diastolic blood pressures, as compared to premenopausal women. Conversely, they had lower HDL-cholesterol and apolipoprotein A-I mean values. Men had also higher mean values for BMI, waist and hip circumferences and WHR. Indeed, despite the large range of WHR values within each sex, from 0.620 to 1.022 in women and from 0.727 to 1.097 in men, the women's values of WHR were clearly grouped on the left part of the distribution (Figure 1 ). The 90th percentile of WHR among women (equal to 0.846) corresponded approximately to the 20th percentile of WHR among men (equal to 0.848). However, there was an overlap between the sexes: 64% of the women and 82% of the men had a WHR 0.75 and`0.95. Furthermore, since BMI and WHR were positively correlated, r 0X55 (P`0.001) in men and r 0X42 (P`0.001) in women, mean BMI increased with increasing WHR in both sexes, but for a similar WHR, women had a higher mean BMI than men.
There were no consistent changes of the mean total cholesterol controlled for age and BMI across WHR Figure 1 Waist to hip ratio (WHR) for men and premenopausal women (the distribution was divided into equal intervals of length 0.5 units), and mean value of body mass index by sex and WHR class. The D.E.S.I.R. Study.
Abdominal body fat distribution and cardiovascular risk factors S Bertrais et al classes in women (Figure 2 ), but in men there was a progressive increase (P for linear trend`0.0001). The mean levels of LDL-cholesterol varied similarly (data not shown): the adjusted mean levels of men increased from 3.17 mmolal for 0.75 WHR`0.80 to 3.69 mmolal for WHR 1.00 (P for linear trend 0.0001). In contrast, the mean concentrations of HDL-cholesterol clearly reduced along the WHR intervals, with a 24% decrease from 0.65 WHR`0.70 to 0.90 WHR`0.95 in women (P for linear trend`0.0001). Although the trend was not signi®cant in men (79% from 0.80 WHR`0.85 to WHR 1.00), the continuous decrease from women to men according to WHR was the more evident for HDL than for total cholesterol: in all BMI classes, the mean level of HDL-cholesterol was the highest for women with a WHR between 0.65 and 0.70; the lowest mean was observed for men with WHR 1.00, except in the ®rst tertile of BMI where there were fewer than 30 men. The mean triglyceride concentrations were also strongly related to WHR within and across sexes (Figure 2 ). They increased by 66% across the WHR classes for men (P for linear trend`0.0001) and by 47% for women (P for linear trend`0.0001). Moreover, men and women in the same BMI tertile who had similar WHR, had almost the same mean triglyceride value. In the same way, on average the apolipoprotein-B concentrations increased with WHR, especially in the men in the middle and highest tertiles of BMI, whereas the apolipoprotein A-I mean levels (data not shown) varied inversely with abdominal adiposity. In addition, the decrease of apolipoprotein A-I was more marked in women (from 170 mgadl for 0.65 WHR`0.70 to 157 mgadl for 0.90 WHR`0.95, P for linear trend`0.0001) and, for a given age and BMI, men retained lower mean levels of apolipoprotein A-I than women of the same WHR.
The systolic (data not shown) and diastolic blood pressures ( Figure 3 ) were more modestly but signi®-cantly associated with WHR in both sexes. In men, the difference of the means between the extreme WHR classes were 3.5 mmHg for systolic and 4.4 mmHg for diastolic blood pressures, the differences were respectively 7.2 mmHg and 5.0 mmHg in women. The mean fasting glucose increased slightly with increasing WHR (Figure 4) , except for the men in the highest BMI tertile; where there was an overlap of the WHR sex-distributions, men had higher mean glucose values than women. The variations of fasting insulin with abdominal fat were quite different. Indeed, in spite of the gradual increase with WHR in both men and women (P for linear trend`0.0001), the levels for men were consistently lower than those of premenopausal women within each BMI group, even if they had a more pronounced abdominal fat distribution.
We further investigated the factors that were likely to be implicated in the sex differential in metabolic parameter levels. First of all, men had more unhealthy behavioural characteristics: 37% of men had a low overall physical activity (vs 33% of women, P0
.02) and they were also more frequently current or former smokers (67% vs 32%, P`0.001). Their alcohol consumption was also higher: 58% of men had a daily alcohol intake 20 gaday in comparison to 6% of women (P`0.001). Multivariate linear regression analysis showed that these behavioural factors did not fully explain the difference for most of the cardiovascular risk factors between men and premenopausal women, as sex signi®cantly increased the variance explained (total r 2 ) in all cardiovascular risk factors, after controlling for age, BMI and lifestyle habits (Table 2) ; the only exception was for insulin. Adding WHR, rather than sex, increased the variance explained for all cardiovascular risk factors. Abdominal body fat distribution and cardiovascular risk factors S Bertrais et al Figure 2 Total and high-density lipoprotein (HDL) cholesterol, triglyceride and apolipoprotein-B means adjusted for age and body mass index (BMI) by waist to hip ratio (WHR) and age-adjusted mean values by WHR and by tertile of BMI in each sex. Men and premenopausal women from the D.E.S.I.R. Study.
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Moreover, after controlling for WHR, sex had no additional effect on total cholesterol (P`0.009 for change in total r 2 ) and triglycerides (P`0.40 for change in total r 2 ), whereas WHR increased the explained variance after accounting for sex. As for the other cardiovascular risk factors, both sex and WHR signi®cantly increased the total variance explained, with and without controlling for each other. than premenopausal women of the same age. Men had higher blood pressures, as well as unfavourable levels of lipoproteins, and of fasting glucose and insulin. On average men also had a higher BMI, but for a similar WHR, their relative weight was lower than that of premenopausal women of the same age. Therefore, it was necessary to control for these differences in BMI when comparing the levels of cardiovascular risk factors for a given WHR between men and women. 36 As for behavioural characteristics, men were more frequently cigarette smokers. In our sample, a sedentary way of life, de®ned as an irregular playing of sport and a low or moderate physical activity at work andaor at home, was also more frequent among men, whereas lower physical activity in women has been observed in most other studies. 23 In contrast, men reported a higher alcohol consumption, which is potentially a cardioprotective factor 37 but may have a deleterious effect on the abdominal distribution of body fat. 27 However, these differences in behaviours and relative weight explained little of the worse cardiovascular pro®le of men, since adding sex in the multivariate regression models signi®cantly increased the variance explained for most cardiovascular risk factors. Similar conclusions were made in a study of healthy Chinese urban workers. 24 In agreement with these observations, the gender differences in lifestyle habits do not seem to fully explain the higher rate of CVD among men. 5 Furthermore, we demonstrate gradual relationships between the extent of abdominal adipose tissue and the levels of lipids and lipoproteins within and across sexes. Moreover, our data showed that middle-aged men and women with similar WHR and BMI had the same levels of triglycerides; accordingly after adjusting for age, lifestyle, BMI and WHR, gender was no longer related to triglyceride levels. Similar results were observed for total cholesterol, although in women total cholesterol was not associated with abdominal body fat distribution after taking into account age and BMI. In contrast, adjusting for confounding factors and WHR was not suf®cient to eliminate the sex differences in HDL-and LDLcholesterol, nor in apolipoprotein A-I and B, but WHR was independently related to these cardiovascular risk factors for a given sex. Overall, our results agree with previous studies which found that an abdominal fat pattern may partially account for the gender differences in these cardiovascular risk factors, 23 ± 25 even after taking into account age, relative weight and the possible confounding in¯uence of gender speci®c lifestyle factors. As for systolic and diastolic blood pressures, they were poorly related with WHR after adjustment for age and BMI; sex was independently related to blood pressure after adjusting for covariates and WHR explained little more of the variance.
The degree of resistance to insulin-stimulated glucose uptake and the level of insulin are known to be closely associated with the lipoprotein metabolism, especially high levels of triglycerides and low-levels of HDL-cholesterol. 18 According to our results, fasting insulin was also positively related with the WHR in both sexes. As fasting insulin may be a surrogate measure of insulin resistance in glucose tolerant subjects, 38 our results are concordant with some previous ®ndings from studies using an oral glucose tolerance test 39, 40 or a hyperinsulinaemic euglycaemic clamp. 41 However, the results from previous studies on insulin sensitivity are controversial; it has also been found using the hyperinsulinaemic euglycaemic clamp, that women had both lower fasting glucose concentrations and a greater insulin-mediated glucose disposal (lower insulin resistance). 42, 43 Furthermore, according to our data the level of fasting insulin appears to be sexdependent: women always had a higher mean fasting insulin than men, even if they had less abdominal fat. Using the homeostasis model (HOMA), we estimated b-cell insulin-secretion and insulin resistance from fasting glucose and insulin concentrations (data not shown). 44, 45 For a similar WHR, we con®rmed a greater insulin resistance in premenopausal women than in men, and observed a higher insulin secretion, even after adjustment for glucose. Thus the higher levels of fasting insulin of women are confounded by their greater insulin secretion. 46, 47 Moreover, the HOMA insulin resistance index showed the same trend as fasting insulin with WHR in both sexes, whereas the age and BMI-adjusted mean b-cell secretion of insulin appeared to increase sharply in the higher WHR classes for women, suggesting that the etiology, and potentially the related metabolic alterations, of the hyperinsulinaemia may differ between abdominal obese men and women.
Although fasting insulin was higher in women than in men at similar levels of abdominal fat, they had lower levels of other cardiovascular risk factors. Indeed the womens' levels of fasting glucose and blood pressures, as well as the lipoprotein pro®le remained better than those of men. Conversely, in the higher WHR classes where men were overrepresented, fasting insulin reached the highest levels seen in the women and all other cardiovascular risk factors were increased. Most prospective strudies in women failed to demonstrate that fasting insulinaemia is an independent predictor of CVD. 48, 49 As a consequence, putting forward a gender-speci®c susceptibility to high levels of insulin, some authors suggest that hyperinsulinaemia, as a marker of insulin resistance, is responsible for the discrepancy in CVD rates between men and women. 49 However this hypothesis Abdominal body fat distribution and cardiovascular risk factors S Bertrais et al is not supported by the increased cardiovascular risk in women with impaired glucose tolerance, 50 nor the lost relative protection in diabetic women. 13 In addition, the independent predictive power of fasting insulin has not been reported in all studies of men. 51 ± 53 Fontbonne 54 suggested that hyperinsulinaemia is probably related to cardiovascular risk, through its strong associations with other cardiovascular risk factors, especially abdominal fat distribution. Instead, the more pronounced abdominal fat distribution in men and to a lesser extent in diabetic women, may more consistently explain their higher cardiovascular risk in comparison to premenopausal non-diabetic women.
Some authors have recently questioned the role of an abdominal fat distribution per se in the development of chronic diseases, especially cardiovascular events, because of the lack of``undoubtable epidemiological evidence''. 36 Our results con®rm that high amounts of abdominal adipose tissue are strongly associated with metabolic and clinical abnormalities, as described by the insulin resistance syndrome. 22 We also demonstrate that these relationships are independent of age, BMI and lifestyle factors, including smoking status, overall physical activity and alcohol consumption. Furthermore, the observed continuum across the WHR values and, particularly, the overlap from women to men emphasizes the predominant role of the abdominal distribution of fat on the cardiovascular risk pro®le and leads us to infer that the effect of WHR is not sex speci®c. Because of the design of our study, we cannot conclude that there is a causal relationship between WHR and other metabolic risk factors levels, but some prospective studies have reported that the abdominal adipose tissue is a strong predictor of metabolic deterioration. 20, 55 In addition, there are plausible biological mechanisms which suggest a possible direct in¯uence of abdominal fat on the cardiovascular risk pro®le. Visceral fat, which is closely associated with WHR, 56, 57 has been shown to be more metabolically active than subcutaneous fat, with an accelerated turnover of lipid synthesis and mobilization, resulting in an increased free fatty acid (FFA)¯ux to the liver. This higher release of FFA from visceral adipocytes has been thought to have adverse effects in the liver, including aberrations in insulin action and metabolism, as well as stimulation of very low density lipoproteins and apo-B production, leading to increased availability of triglycerides and increased LDL-cholesterol production. 58 Other mechanisms are probably involved since the gender differences in body fat distribution do not entirely explain the variability in other cardiovascular risk factors, as shown by our data.
Although our results are consistent with the literature, some aspects of the study design should be considered. Firstly BMI was the only available measure of overall adiposity in our study. Taking into account BMI probably does not fully eliminate the confounding effect of body fat in the relationships between WHR and cardiovascular risk factors, especially when comparing men and women. 36, 59 Indeed, some authors demonstrated that BMI is not a comparable measure of body fatness in both sexes: women have greater amounts of total body fat than men for a similar BMI. 59 It has been also demonstrated, in both white men and women, aged 20 ± 45 y, that BMI is a poorer marker of the percentage of body fat in the lower BMI tertiles than in the upper BMI; conversely, low and normal BMI values were more correlated with fat-free mass, 60 an indicator of muscle mass which is greatly in¯uenced by stature, in women in particular.
Our measure of abdominal body fat distribution, the ratio of the waist to hips girths, is a simple index to quantify the abdominal body fat distribution in a large population. However, there has been increasing evidence that the accumulation of visceral fat, rather than the extent of subcutaneous adipose tissue, 20, 40, 61 is related to the unhealthier cardiovascular risk pro®le. Unfortunately, our anthropometric indicator does not allow us to distinguish the different adipose tissue components, in contrast to technical methods such as computed tomography and magnetic resonance imaging. Despite this potential disadvantage, the WHR is thought to give a good estimation of the abdominal fat, which is more highly associated with visceral fat than with subcutaneous fat. 56, 57 Some authors suggest that the ratio of the waist to thigh circumferences is a more reliable measure than the WHR for men, 62 but not for women, 57, 62 and the thigh circumference is also more dif®cult to measure because of imprecise positioning which may lead to inaccurate results. This drawback is also imputed to the use of the abdominal sagittal diameter, which is the best surrogate measure of visceral fat. 63 As for waist circumference alone, it correlates better to abdominal visceral adipose tissue accumulation than WHR, 63 but waist girth is more strongly correlated to BMI than WHR, especially in the present study. In our population, WHR and waist showed similar associations with the levels of other cardiovascular risk factors after adjusting for age and BMI. In addition, the WHR has been shown to be a stronger predictor for cardiovascular mortality and morbidity than the waist circumference. 6, 8 
Conclusions
Our ®ndings con®rm in a population of healthy French adults that men have a more atherogenic risk pro®le than premenopausal women of similar age. We demonstrated that the levels of most of the cardiovascular risk factors are dose-related with the extent of the abdominal body fat distribution, as re¯ected by the WHR. Consequently, this study suggests that the gender differences in lipids and lipoproteins, fasting glucose and insulin are substantially but not entirely explained by the amount of abdominal adipose tissue, even after adjustment for age, relative weight and the possible confounding in¯uence of lifestyle factors.
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